InvestorsHub Logo

KCRoyal2004

08/26/20 6:52 PM

#111406 RE: SmileyRiley_595 #111404

Smiley, I totally believe that. Through my correspondence, BP seems like a great guy that isn't "wired" that way. I am sure that he never saw it coming. Lots of POS out there......

tikotiko

08/26/20 7:27 PM

#111416 RE: SmileyRiley_595 #111404

Great job Riley, thanks!

DiscusDude

08/26/20 7:30 PM

#111417 RE: SmileyRiley_595 #111404

Thanks again for this. Really appreciate your insight.

d0lphint0m

08/26/20 7:45 PM

#111419 RE: SmileyRiley_595 #111404

Wursthorn led me to believe it would be positive as well when he interviewed me. I asked him 3 times (separate) to interview Misiu, stating her knowledge, as a doctor was superior to most people on the history and clinical data on Leronlimab. He assured me he would interview her. I was very very disappointed

ombowstring

08/27/20 10:35 AM

#111637 RE: SmileyRiley_595 #111404

Did CytoDyn and Patterson in fact receive an email from OWS and decide not to proceed or just haven't done so yet? Will the WSJ be issuing a retraction?

In the proactive interview, Nader says he hasn't applied for BARDA funding, but in the WSJ article, Wursthorn wrote that CytoDyn has applied to BARDA and has been turned down, correct? Could it be that Wursthorn is seriously short the stock and working in collusion with other shorts?